bough

[bough @firebutworking]

$CING CRL "Cingulate expects a prompt submission to FDA of the requested information addressing issues raised."

[bough @firebutworking]

$CING halted. PDUFA decision?

[bough @firebutworking]

damn, imagine you have to work at 90 because your largest position got a 50% haircut today. SAD

[bough @firebutworking]

Be humble. And be careful who you worship. Some arrogant idiots don't know shit.

[bough @firebutworking]

$abvx Cancer risk.

[bough @firebutworking]

$abvx halt

[bough @firebutworking]

Syntone Technologies Group is also a major shareholder of $OTLK and sits on the board, will they get a similar deal as GMS Ventures?
https://t.co/JtLsKPVPVN

[bough @firebutworking]

@Biotenic Best of luck!

[bough @firebutworking]

damn, I was asked to file SEC form 13H now.
It's a milestone, but what a hassle!

[bough @firebutworking]

This is why I love shity biotechs like
$OTLK
. It always came back to give you opportunities reload. Huge range, huge volume.

[bough @firebutworking]

Historically $OTLK had been consistently valued around $250m-300m. Given recent dilution and warrants and future offering, 120M float + 60M warrants+future offering, $1 target is achievable in the near term

[bough @firebutworking]

@Respekchemistry Of course. A guy who makes money off clicks is certainly jealous of people who make real money

[bough @firebutworking]

$HOTH Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies. WTF

[bough @firebutworking]

$qncx they front ran the licensing and PIPE and it back fired. The shell play no longer a no brainer.

[bough @firebutworking]

$SACH

[bough @firebutworking]

$NVDA's stake in $GENB is several years old news!

[bough @firebutworking]

I am up over 40% YTD but feel like a loser when I look at those AI stocks. @Respekchemistry is going to mock me lol. Am a bit outdated but will have to stick to what I understand.

[bough @firebutworking]

@alex__pitti No, but I don't burn 20M/Q as well LOL

[bough @firebutworking]

$MIST "Product revenues were $0.2 million during the three months ended March 31, 2026." I made more money than the company in Q1. Wondering if I IPO myself, would I get $200M valuation? LOL

[bough @firebutworking]

@Respekchemistry Even the most idiot $UNCY management who kept selling shares via ATM along the way can't stop the 100% runup from $4. $MIST still ran up 100% from that giant offering at $1.5 with 200% warrant coverage. This pattern is one of the most reliable set-ups in small cap bios.

[bough @firebutworking]

$SRPB "anticipated BLA submission in the fourth quarter of 2026."... "Extending Cash Runway into the Second Half of 2027 and Beyond Anticipated Potential FDA Approval of TA-ERT"

Clean de-risked PDUFA rup-up play.